Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lymphoma, B-Cell × Tretinoin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Lymphoma, B-Cell 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1

Interventions

fludarabine 3 Cyclophosphamide 3 relmacabtagene autoleucel 2 Rituximab 2 ALT-803 2 zanubrutinib 1 tisagenlecleucel 1 tafasitamab 1 resiniferatoxin 1 obinutuzumab 1 Tretinoin 1 Radiotherapy 1 Nivolumab 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Ruijin Hospital

Phase 2 Not yet recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡